The Interstitium in the Hypertrophied Heart

Area of Science:

• Cardiology
• Pathology
• Biomedical Engineering

Background:

• Pathological left ventricular hypertrophy (LVH) is a common cardiac disease complication.
• LVH results from myocyte hypertrophy and interstitial expansion.
• Interstitial expansion, primarily interstitial fibrosis, stems from collagen accumulation due to various stimuli.

Purpose of the Study:

• To highlight the significance of interstitial disease in cardiac pathology.
• To underscore the need for novel therapies targeting interstitial disease pathways.
• To emphasize the importance of characterizing interstitial disease for personalized medicine.

Main Methods:

• Review of existing literature on left ventricular hypertrophy and interstitial disease.
• Analysis of the mechanisms driving interstitial fibrosis and other forms of interstitial expansion.
• Discussion of the association between interstitial disease extent and adverse cardiac outcomes.

Main Results:

• Interstitial fibrosis, caused by collagen accumulation, is a major contributor to interstitial expansion in LVH.
• Other causes of interstitial expansion include amyloid protein buildup and edema.
• The extent and type of interstitial disease correlate with poor patient outcomes.

Conclusions:

• Accurate characterization of interstitial disease is crucial for developing targeted therapies.
• Personalized therapeutic strategies for LVH require precise assessment of interstitial pathology.
• Further research into novel therapeutic targets for interstitial disease is warranted.